Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BAYER AG : Barclays reiterates its Neutral rating

11/16/2021 | 08:12am EST

In a research note published by Emily Field, Barclays gives a Neutral rating to the stock. The target price is unchanged and still at EUR 50.


ę MarketScreener with dpa-AFX Analyser 2021
All news about BAYER AG
01/27Simbiose Agro acquired Biagro S.A. from Bayer Aktiengesellschaft.
CI
01/21MustGrow Biologics Up 7.6% after Reporting Exclusive Agreement with Bayer
MT
01/19BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patie..
AQ
01/17Factbox-GSK's consumer healthcare business coveted by Unilever
RE
01/17BAYER : Annual Bayer Pharma Media Day 2022
PU
01/15Factbox-GSK's consumer health business
RE
01/12BAYER AG : JP Morgan keeps its Buy rating
MD
01/11Netafim USA and Bayer Partners to Launch the “Precise Defense” Crop Protectio..
CI
01/10Correction to Bayer Gene Editing Article
DJ
01/10Bayer to Collaborate on Gene Editing Technology With Mammoth Biosciences
DJ
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2021 43 078 M 48 019 M 48 019 M
Net income 2021 459 M 511 M 511 M
Net Debt 2021 37 821 M 42 159 M 42 159 M
P/E ratio 2021 83,8x
Yield 2021 3,87%
Capitalization 51 901 M 57 932 M 57 855 M
EV / Sales 2021 2,08x
EV / Sales 2022 1,97x
Nbr of Employees 99 814
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 52,83 €
Average target price 64,23 €
Spread / Average Target 21,6%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG12.40%57 932
JOHNSON & JOHNSON0.42%452 254
ROCHE HOLDING AG-6.24%308 691
PFIZER, INC.-7.99%304 947
ABBVIE INC.1.86%243 826
ELI LILLY AND COMPANY-11.27%222 206